paclitaxel has been researched along with Neoplasms, Vascular in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, T; Gyoten, K; Hayasaki, A; Iizawa, Y; Isaji, S; Kishiwada, M; Komatsubara, H; Kuriyama, N; Maeda, K; Mizuno, S; Murata, Y; Nakagawa, Y; Noguchi, D; Sakurai, H; Shinkai, T; Tanemura, A | 1 |
| Albrecht, T; Kutschera, M; Schnorr, B; Waliszewski, MW | 1 |
| Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM | 1 |
| Katakami, N; Nakahira, A; Ogino, H; Sasaki, H | 1 |
| Bellinvia, M; Boneschi, V; Brambilla, L; Ferrucci, S; Miedico, A; Romanelli, A; Tedeschi, L; Vinci, M | 1 |
2 trial(s) available for paclitaxel and Neoplasms, Vascular
| Article | Year |
|---|---|
Phase I Study of Preoperative Chemoradiotherapy Using Gemcitabine Plus Nab-Paclitaxel for Patients Who Have Localized Pancreatic Ductal Adenocarcinoma With Contact or Invasion to Major Arteries.
Topics: Aged; Aged, 80 and over; Albumins; Arteries; Carcinoma, Pancreatic Ductal; Chemoradiotherapy; Deoxycytidine; Feasibility Studies; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Pancreatectomy; Pancreatic Neoplasms; Vascular Neoplasms | 2021 |
Two-Year Mortality After Angioplasty of the Femoro-Popliteal Artery with Uncoated Balloons and Paclitaxel-Coated Balloons-A Pooled Analysis of Four Randomized Controlled Multicenter Trials.
Topics: Age Factors; Aged; Angioplasty, Balloon; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Databases, Factual; Equipment Design; Female; Femoral Artery; Follow-Up Studies; Germany; Humans; Kaplan-Meier Estimate; Male; Paclitaxel; Popliteal Artery; Prospective Studies; Treatment Outcome; Vascular Neoplasms | 2019 |
3 other study(ies) available for paclitaxel and Neoplasms, Vascular
| Article | Year |
|---|---|
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms | 2012 |
Long-term survival of a pulmonary artery sarcoma produced by aggressive surgical resection and adjuvant chemoradiotherapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Chemotherapy, Adjuvant; Humans; Male; Paclitaxel; Pulmonary Artery; Radiotherapy, Adjuvant; Sarcoma; Treatment Outcome; Vascular Neoplasms | 2007 |
Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Male; Microtubules; Middle Aged; Paclitaxel; Sarcoma, Kaposi; Treatment Outcome; Vascular Neoplasms | 2008 |